In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of DBV Technologies ADR (NASDAQ: DBVT) was $16.63 for the day, down -2.12% from the previous closing price of $16.99. In other words, the price has decreased by -$2.12 from its previous closing price. On the day, 0.58 million shares were traded. DBVT stock price reached its highest trading level at $18.1 during the session, while it also had its lowest trading level at $16.49.
Ratios:
Our analysis of DBVT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.80 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.13.
Upgrades & Downgrades
In the most recent recommendation for this company, Cantor Fitzgerald on December 15, 2025, initiated with a Overweight rating and assigned the stock a target price of $42.
On December 03, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $35.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 17 ’25 when EPIC Bpifrance sold 2,076,990 shares for $4.85 per share. The transaction valued at 10,070,232 led to the insider holds 8,595,472 shares of the business.
EPIC Bpifrance sold 1,292,103 shares of DBVT for $5,413,912 on Dec 18 ’25. The Member of 10% owner group now owns 7,303,369 shares after completing the transaction at $4.19 per share. On Nov 20 ’25, another insider, Mohideen Pharis, who serves as the Chief Medical Officer of the company, sold 6,496 shares for $2.88 each. As a result, the insider received 18,708 and left with 103,153 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DBVT now has a Market Capitalization of 772074304 and an Enterprise Value of 2747558400. Its current Enterprise Value per Revenue stands at 499.374.
Stock Price History:
The Beta on a monthly basis for DBVT is -0.98, which has changed by 3.4360313 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, DBVT has reached a high of $26.18, while it has fallen to a 52-week low of $3.30. The 50-Day Moving Average of the stock is 4.07%, while the 200-Day Moving Average is calculated to be 47.29%.
Shares Statistics:
DBVT traded an average of 377.18K shares per day over the past three months and 396280 shares per day over the past ten days. A total of 40.14M shares are outstanding, with a floating share count of 32.94M. Insiders hold about 17.94% of the company’s shares, while institutions hold 33.81% stake in the company. Shares short for DBVT as of 1765756800 were 164840 with a Short Ratio of 0.44, compared to 1763078400 on 32706. Therefore, it implies a Short% of Shares Outstanding of 164840 and a Short% of Float of 0.5.
Earnings Estimates
. The current rating of DBV Technologies ADR (DBVT) is the result of assessments by 4.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.06 and low estimates of -$0.25.
Analysts are recommending an EPS of between -$0.68 and -$0.93 for the fiscal current year, implying an average EPS of -$0.86. EPS for the following year is -$0.46, with 4.0 analysts recommending between -$0.26 and -$0.95.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for DBVT’s current fiscal year. The highest revenue estimate was $6.71M, while the lowest revenue estimate was $4.27M, resulting in an average revenue estimate of $5.33M. In the same quarter a year ago, actual revenue was $3.88M
